InvestorsHub Logo
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

Re: willyw post# 2564

Tuesday, 06/06/2023 12:09:47 PM

Tuesday, June 06, 2023 12:09:47 PM

Post# of 3013

I point out several of your contradictions in your own writings, where you actually lay out your thoughts but you don't or cant explain the error, contradiction or weakness in your argument.
Instead, you change the subject with pure whataboutism.



willyw,

I was going to craft a response to our friend but you beat me to it. You did an excellent job and hit all the points I was going to. Bravo!

I think hearing the bear case is important as the boards often become too much of an echo chamber. However, as you so excellently summarized, our friend is full of distortions, misinformation and inconsistencies. The supposed next generation super anti-Covid drug from PFE is just one glaring example.

I don't know for sure what will happen with EDP-235. It has been less than one month since the phase 2 data of EDP-235 showed a statistically significant reduction in symptoms in this healthy patient population, something Paxlovid failed to do. Does that guarantee a phase 3 success for EDP-235? No, but I think there is a good chance and ENTA is seeking a partner to fund that trial. Any deal takes some time to work out, so we shall see.

As far as our friend, he has never talked about what he feels is a good investment. Moreover, he has only posted since November on Ihub and only on the ENTA board. That seems highly unusual to say the least.

Good luck to you.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News